Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
market exclusivity
Pharma
Court dismisses case against BMS' patent protection of Pomalyst
The lawsuit accused Bristol Myers Squibb of anticompetitive tactics in protecting the market exclusivity of Pomalyst.
Kevin Dunleavy
Apr 9, 2025 11:32am
BMS, Amgen and Pfizer face steepest patent cliffs
Dec 29, 2021 9:56am
Novartis sues FDA, claiming Sanofi's Aubagio isn't really new
Mar 11, 2021 11:34am
Bayer's post-Xarelto, post-Eylea life is better than expected
Mar 10, 2021 12:22pm
Pfizer's Lyrica market share crumbles under generic onslaught
Aug 19, 2019 9:59am
Indivior slashes sales projections in half after $3B indictment
May 2, 2019 11:40am
